辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PFE 辉瑞

盘前交易 07-13 04:18:59 EDT

24.17

-0.08

-0.33%

盘前24.26

+0.09+0.38%

04:18 EDT

最高24.41	最低24.10	成交量2,752万
今开24.35	昨收24.25	日振幅1.30%
总市值1,374亿	流通市值1,364亿	总股本56.86亿
成交额6.67亿	换手率0.49%	流通股本56.44亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PFE","market":"US","secType":"STK","nameCN":"辉瑞","latestPrice":24.17,"timestamp":1783713600000,"preClose":24.25,"halted":0,"volume":27523178,"hourTrading":{"tag":"盘前","latestPrice":24.2616,"preClose":24.17,"latestTime":"04:18 EDT","volume":15486,"amount":375353.725332,"timestamp":1783930708944,"change":0.0916,"changeRate":0.00379,"amplitude":0.005743},"delay":0,"changeRate":-0.003298969072164878,"floatShares":5644296476,"shares":5685707552,"eps":1.312648,"marketStatus":"盘前交易","change":-0.08,"latestTime":"07-13 04:18:59 EDT","open":24.345,"high":24.41,"low":24.095,"amount":667306826.821704,"amplitude":0.01299,"askPrice":24.34,"askSize":250,"bidPrice":24.25,"bidSize":50,"shortable":3,"etf":0,"ttmEps":1.312648,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783949400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":-819144000000,"exchange":"NYSE","adjPreClose":24.17,"dividendRate":0.0712,"preHourTrading":{"tag":"盘前","latestPrice":24.2616,"preClose":24.17,"latestTime":"04:18 EDT","volume":15486,"amount":375353.725332,"timestamp":1783930708944,"change":0.0916,"changeRate":0.00379,"amplitude":0.005743},"postHourTrading":{"tag":"盘后","latestPrice":24.2287,"preClose":24.17,"latestTime":"19:59 EDT","volume":1782764,"amount":43097276.3286,"timestamp":1783727997165,"change":0.0587,"changeRate":0.002429,"amplitude":0.00331},"volumeRatio":0.6165912693836176,"optionData":{"bulkOrders":[{"symbol":"PFE","call":true,"expireDate":1783656000000,"strike":"24.5","timestamp":1783690472564,"price":0.01,"volume":1500,"amount":1500,"type":"-"},{"symbol":"PFE","call":true,"expireDate":1783656000000,"strike":"24.5","timestamp":1783702743373,"price":0.01,"volume":1191,"amount":1191,"type":"-"}]},"impliedVol":0.2616,"impliedVolPercentile":0.444},"requestUrl":"/m/hq/s/PFE","defaultTab":"news","newsList":[{"id":"2650213980","title":"市场消息：美国FDA批准辉瑞Padcev联合Keytruda用于治疗肌层浸润性膀胱癌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2650213980","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650213980?lang=zh_cn&edition=full","pubTime":"2026-07-10 23:26","pubTimestamp":1783697183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0306806265.USD","LU0985481810.HKD","SG9999013999.USD","LU0122379950.USD","SG9999001176.USD","BK4588","IE00BLSP4452.SGD","BK4007","IE00BBT3K403.USD","IE00BLSP4239.USD","LU0868494617.USD","IE00B19Z3581.USD","SG9999003800.SGD","BK4550","BK4599","LU1066051498.USD","SG9999002232.USD","BK4534","SG9999011175.SGD","IE00B3T34201.USD","IE00B19Z3B42.SGD","OZEM","LU0058720904.USD","LU1066053197.SGD","SG9999001176.SGD","BK4581","BK4533","IE0002270589.USD","IE000M9KFDE8.USD","LU0225284248.USD","LU1894683264.USD","LU0289739699.SGD","LU2596442595.SGD","LU1894683348.USD","PFE","LU0170899867.USD","SG9999002224.SGD","LU0225771236.USD","BK4585","LU1883839398.USD","LU0321505439.SGD","LU0456855351.SGD","BK4592","LU0234572021.USD","LU1057294990.SGD","LU1023059063.AUD","SGXZ57979304.SGD","BK4568","LU0321505868.SGD","LU0306807586.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108884610","title":"美国FDA批准Padcev®联合Keytruda®作为肌层浸润性膀胱癌新辅助及辅助疗法，不限顺铂适用性","url":"https://stock-news.laohu8.com/highlight/detail?id=1108884610","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108884610?lang=zh_cn&edition=full","pubTime":"2026-07-10 23:25","pubTimestamp":1783697156,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局已批准将Padcev与Keytruda联合疗法，用于肌层浸润性膀胱癌患者的新辅助及辅助治疗。此项批准的关键在于，无论患者是否符合顺铂化疗的适用条件，均可使用该联合方案。此次批准基于关键的临床研究数据，显示了该联合疗法在目标患者群体中的显著疗效与可管理的安全性。随着监管绿灯的亮起，该方案有望迅速融入临床实践，为肌层浸润性膀胱癌患者提供新的重要治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","LU1883839398.USD","SG9999002224.SGD","IE0002270589.USD","LU0122379950.USD","LU1023059063.AUD","LU1894683348.USD","BK4588","BK4599","SG9999001176.SGD","BK4581","LU0225771236.USD","LU0289739699.SGD","LU1057294990.SGD","PFE","BK4534","BK4550","IE000M9KFDE8.USD","SG9999002232.USD","LU0456855351.SGD","IE00BBT3K403.USD","BK4533","LU0985481810.HKD","IE00B19Z3B42.SGD","BK4568","LU0306807586.USD","LU0225284248.USD","OZEM","BK4592","LU0321505868.SGD","LU0170899867.USD","IE00BLSP4452.SGD","LU0234572021.USD","LU0868494617.USD","LU0321505439.SGD","LU1894683264.USD","BK4007","IE00B19Z3581.USD","SG9999013999.USD","LU2596442595.SGD","SGXZ57979304.SGD","SG9999003800.SGD","LU0306806265.USD","LU1066051498.USD","SG9999011175.SGD","SG9999001176.USD","IE00B3T34201.USD","LU0058720904.USD","BK4585","LU1066053197.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162268794","title":"FDA批准帕博利珠单抗或帕博利珠单抗联合贝拉海藻糖酶Alfa-pmph，各自与恩福妥单抗Vedotin-ejfv联用，治疗肌层浸润性膀胱癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1162268794","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162268794?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:28","pubTimestamp":1783693688,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已批准帕博利珠单抗，或帕博利珠单抗联合贝拉海藻糖酶Alfa-pmph，各自与恩福妥单抗Vedotin-ejfv联用，用于治疗肌层浸润性膀胱癌。这一决定为患者提供了一种新的联合治疗方案选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","LU0965509010.AUD","LU2491050154.USD","LU2361044865.SGD","LU0211331839.USD","FHLC","IE0009355771.USD","LU0122379950.USD","SG9999013999.USD","LU1894683348.USD","LU1093756168.USD","LU1923622614.USD","BK4568","IE00BJJMRZ35.SGD","IE00B1BXHZ80.USD","BK4516","LU0130102774.USD","LU0306806265.USD","LU0306807586.USD","LU1061106388.HKD","LU1162221912.USD","IE00B19Z3B42.SGD","BK4533","LU0265550359.USD","LU0965509101.SGD","SG9999002232.USD","LU1917777945.USD","LU2125154778.USD","LU2023250843.SGD","OZEM","LU1116320901.HKD","LU2089984988.USD","LU2106854487.HKD","VHT","GDOC","IE00BFTCPJ56.SGD","LU1201861249.SGD","LU1066051811.HKD","LU0859254822.USD","SG9999014559.SGD","LU0868494708.USD","LU0289739699.SGD","SG9999011175.SGD","LU2125909593.SGD","LU1983299246.USD","XLV","BK4592","LU1989772923.USD","IE00B2B36J28.USD","IE000M9KFDE8.USD","BK4007","LU1037948897.HKD","IE0002141913.USD","LU1093756325.SGD","LU0070302665.USD","IE00B4R5TH58.HKD","LU0648001328.SGD","LU1057294990.SGD","LU1941712348.USD","IE00BLSP4239.USD","LU1430594728.SGD","LU2491050071.SGD","PPH","LU0320765646.SGD","LU2023250504.SGD","BK4534","IYH","SG9999003800.SGD","SG9999015358.SGD","IHE","IE00BLSP4452.SGD","BK4581","BK4559","SG9999001176.USD","IE00BN8TJ469.HKD","JDOC","LU0942090050.USD","LU2125154935.USD","IE00BBT3K403.USD","LU1571399168.USD","SG9999001176.SGD","LU1585245621.USD","LU1066051498.USD","LU2361045086.USD","LU0130517989.USD","LU0203347892.USD","LU0868494617.USD","LU1934455863.HKD","LU1894683264.USD","SG9999002224.SGD","LU0477156953.USD","BK4585","PFE","IE00B3T34201.USD","LU0238689110.USD","LU2461242641.AUD","LU0225284248.USD","LU2360032135.SGD","IXJ","LU0225771236.USD","LU1066051225.USD","LU0965508806.USD","LU0170899867.USD","BK4599","LU2357627491.SGD","IE0002270589.USD","LU1037948541.HKD","HRTS","LU1989772840.SGD","LU1291159041.SGD","LU1116320737.USD","IE00B19Z3581.USD","LU0985320562.USD","LU2361044949.HKD","LU1934455194.USD","LU0321505439.SGD","LU0234572021.USD","LU2468319806.SGD","IE00BSNM7G36.USD","LU2125909247.SGD","SG9999015341.SGD","BMED","LU0861579265.USD","LU1035773651.USD","SG9999001440.SGD","LU1989771016.USD","LU0208291251.USD","LU0098860793.USD","LU0432979614.USD","LU1883839398.USD","IE00BJT1NW94.SGD","LU1929549753.HKD","BK4588","LU1974910355.USD","LU2324357040.USD","LU0266013472.USD","LU1066053197.SGD","LU2433249047.HKD","SGXZ57979304.SGD","LU2491049909.HKD","LU0058720904.USD","LU0965509283.SGD","SG9999014542.SGD","LU0321505868.SGD","LU0203345920.USD","LU0320765489.SGD","SG9999014567.USD","LU0265550946.USD","RXL","SG9999014575.USD","LU1699723380.USD","MRK","LU1023059063.AUD","LU0980610538.SGD","LU1069347547.HKD","LU2112291526.USD","LU1934455277.USD","BK4550","LU0985481810.HKD","LU1941712264.USD","LU0106261372.USD","LU0006306889.USD","PAWZ","LU2596442595.SGD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650413133","title":"美银：将辉瑞目标价下调至26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650413133","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650413133?lang=zh_cn&edition=full","pubTime":"2026-07-10 21:55","pubTimestamp":1783691724,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["SGXZ57979304.SGD","IE000M9KFDE8.USD","BK4007","IE00B19Z3B42.SGD","OZEM","LU0225284248.USD","LU0456855351.SGD","BK4533","LU0122379950.USD","IE0002270589.USD","LU0289739699.SGD","IE00BLSP4452.SGD","BK4588","LU1883839398.USD","PFE","SG9999002224.SGD","LU0321505439.SGD","BK4581","LU0306806265.USD","SG9999011175.SGD","LU1057294990.SGD","BK4550","LU0868494617.USD","BK4568","LU1894683348.USD","LU0985481810.HKD","IE00BLSP4239.USD","BK4534","BK4592","LU0306807586.USD","LU1023059063.AUD","LU1066051498.USD","LU1066053197.SGD","SG9999001176.USD","SG9999013999.USD","LU0225771236.USD","LU0234572021.USD","BK4599","SG9999003800.SGD","LU0321505868.SGD","SG9999001176.SGD","IE00B19Z3581.USD","IE00BBT3K403.USD","SG9999002232.USD","IE00B3T34201.USD","LU0170899867.USD","LU0058720904.USD","LU2596442595.SGD","BK4585","LU1894683264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650927491","title":"平安好医生与辉瑞中国达成合作 持续探索“医药险患”融合路径","url":"https://stock-news.laohu8.com/highlight/detail?id=2650927491","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650927491?lang=zh_cn&edition=full","pubTime":"2026-07-09 21:47","pubTimestamp":1783604820,"startTime":"0","endTime":"0","summary":"本报讯 近日，平安健康医疗科技有限公司宣布与辉瑞投资有限公司达成深度合作，双方将共同打造“医药险商业闭环”与“医药患全病程管理”双闭环体系，持续探索医、药、险、患融合路径。据悉，双方还将持续围绕肿瘤、罕见病、疫苗及代谢健康等领域展开合作探索。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-07-09/doc-inihfpqx5264182.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-07-09/doc-inihfpqx5264182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1247","LU0985481810.HKD","OZEM","BK4568","BK1617","LU0306806265.USD","IE00B19Z3B42.SGD","BK1615","BK4592","LU0868494617.USD","LU0058720904.USD","IE0002270589.USD","BK4550","LU0289739699.SGD","BK4585","SG9999001176.SGD","SG9999003800.SGD","LU0225284248.USD","BK1142","LU0306807586.USD","BK1515","BK1571","LU0456855351.SGD","LU0122379950.USD","LU1894683264.USD","PFE","LU1057294990.SGD","LU1066053197.SGD","BK4533","LU0170899867.USD","LU0234572021.USD","SG9999001176.USD","01833","IE00BBT3K403.USD","BK4534","IE00B19Z3581.USD","BK4599","BK4588","LU2596442595.SGD","SGXZ57979304.SGD","IE00B3T34201.USD","LU0321505439.SGD","BK4007","LU1023059063.AUD","LU1894683348.USD","IE00BLSP4452.SGD","SG9999002224.SGD","SG9999013999.USD","LU0321505868.SGD","LU0225771236.USD","BK4581","LU1066051498.USD","IE00BLSP4239.USD","LU1883839398.USD","SG9999011175.SGD","BK1219","SG9999002232.USD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650948115","title":"小摩下调辉瑞目标价至28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650948115","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650948115?lang=zh_cn&edition=full","pubTime":"2026-07-09 11:23","pubTimestamp":1783567411,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4599","IE00B19Z3581.USD","IE00BBT3K403.USD","LU0306807586.USD","LU0456855351.SGD","SG9999003800.SGD","IE00BLSP4239.USD","BK4007","SG9999013999.USD","LU0122379950.USD","LU1894683348.USD","LU0289739699.SGD","LU0225284248.USD","LU0985481810.HKD","PFE","IE00BLSP4452.SGD","OZEM","LU0234572021.USD","LU1057294990.SGD","LU0058720904.USD","LU0170899867.USD","BK4585","LU0225771236.USD","LU0321505439.SGD","SG9999002232.USD","LU1894683264.USD","IE0002270589.USD","IE00B3T34201.USD","SGXZ57979304.SGD","IE000M9KFDE8.USD","SG9999011175.SGD","LU1066051498.USD","SG9999002224.SGD","BK4533","BK4568","LU0306806265.USD","LU1883839398.USD","LU0321505868.SGD","BK4581","BK4534","BK4588","BK4592","LU2596442595.SGD","SG9999001176.USD","SG9999001176.SGD","IE00B19Z3B42.SGD","LU1066053197.SGD","LU1023059063.AUD","LU0868494617.USD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649600387","title":"强强联合！平安好医生(01833)携手辉瑞中国打造“医药险患”一体化融合新标杆","url":"https://stock-news.laohu8.com/highlight/detail?id=2649600387","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649600387?lang=zh_cn&edition=full","pubTime":"2026-07-07 16:05","pubTimestamp":1783411506,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2026年7月7日，平安好医生与辉瑞中国达成深度合作，依托平安医健服务、商保支付、企业健康管理服务、AI医疗、全病程管理与亿级用户底盘，结合辉瑞在创新药研发、循证医学等领域的优势，双方将共同打造“医药险商业闭环”与“医药患全病程管理”双闭环体系，树立国内医、药、险、患一体化融合标杆。平安好医生CEO何明科表示，医药险深度融合是互联网医疗核心发展方向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464043.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4599","IE00B19Z3581.USD","159938","IE00BBT3K403.USD","LU0306807586.USD","09939","SG9999003800.SGD","IE00BLSP4239.USD","SG9999013999.USD","LU0122379950.USD","BK1219","LU0289739699.SGD","LU0225284248.USD","BK1142","PFE","01833","IE00BLSP4452.SGD","OZEM","LU0234572021.USD","BK1161","LU1057294990.SGD","LU0058720904.USD","LU0170899867.USD","BK4585","BK1615","LU0321505439.SGD","SG9999002232.USD","LU1894683264.USD","IE0002270589.USD","IE00B3T34201.USD","BK1571","SGXZ57979304.SGD","IE000M9KFDE8.USD","SG9999011175.SGD","LU1066051498.USD","BK1574","BK4533","LU1883839398.USD","LU0321505868.SGD","BK4588","BK1617","BK4592","LU2596442595.SGD","SG9999001176.USD","SG9999001176.SGD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU0868494617.USD","BK4550","BK1247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649643195","title":"汇丰将辉瑞目标股价从32美元下调至28美元，将评级从买入下调至持有。","url":"https://stock-news.laohu8.com/highlight/detail?id=2649643195","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649643195?lang=zh_cn&edition=full","pubTime":"2026-07-06 13:19","pubTimestamp":1783315199,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4550","BK4568","LU0225284248.USD","LU0321505868.SGD","IE00BBT3K403.USD","LU1894683348.USD","LU1066053197.SGD","LU1066051498.USD","LU0234572021.USD","PFE","SG9999013999.USD","BK4534","BK4581","LU0868494617.USD","LU1894683264.USD","LU0306807586.USD","LU1023059063.AUD","LU1057294990.SGD","SGXZ57979304.SGD","LU0321505439.SGD","IE00B19Z3B42.SGD","SG9999002232.USD","LU0058720904.USD","IE00BLSP4239.USD","LU0122379950.USD","SG9999002224.SGD","LU0456855351.SGD","IE00BLSP4452.SGD","LU0985481810.HKD","LU2596442595.SGD","IE00B3T34201.USD","SG9999001176.SGD","SG9999011175.SGD","SG9999003800.SGD","BK4592","IE0002270589.USD","LU0225771236.USD","IE00B19Z3581.USD","LU1883839398.USD","BK4599","BK4585","BK4007","BK4533","SG9999001176.USD","IE000M9KFDE8.USD","LU0306806265.USD","LU0170899867.USD","BK4588","OZEM","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647955270","title":"辉瑞股价下跌1.4%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2647955270","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647955270?lang=zh_cn&edition=full","pubTime":"2026-06-30 22:42","pubTimestamp":1782830532,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4550","BK4568","LU0225284248.USD","LU0321505868.SGD","IE00BBT3K403.USD","LU1894683348.USD","LU1066053197.SGD","LU1066051498.USD","LU0234572021.USD","PFE","SG9999013999.USD","BK4534","BK4581","LU0868494617.USD","LU1894683264.USD","LU0306807586.USD","LU1023059063.AUD","LU1057294990.SGD","SGXZ57979304.SGD","LU0321505439.SGD","IE00B19Z3B42.SGD","SG9999002232.USD","LU0058720904.USD","IE00BLSP4239.USD","LU0122379950.USD","SG9999002224.SGD","LU0456855351.SGD","IE00BLSP4452.SGD","LU0985481810.HKD","LU2596442595.SGD","IE00B3T34201.USD","SG9999001176.SGD","SG9999011175.SGD","SG9999003800.SGD","BK4592","IE0002270589.USD","LU0225771236.USD","IE00B19Z3581.USD","LU1883839398.USD","BK4599","BK4585","BK4007","BK4533","SG9999001176.USD","IE000M9KFDE8.USD","LU0306806265.USD","LU0170899867.USD","BK4588","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182051396","title":"辉瑞加拿大公司：加拿大批准用于无法接受顺铂治疗的肌层浸润性膀胱癌患者的围手术期治疗方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1182051396","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182051396?lang=zh_cn&edition=full","pubTime":"2026-06-29 21:08","pubTimestamp":1782738510,"startTime":"0","endTime":"0","summary":"加拿大监管机构已批准一种新的围手术期治疗方案，适用于无法耐受顺铂基础疗法的肌层浸润性膀胱癌患者。这一进展为这部分患者群体提供了重要的临床选择。该方案旨在在手术前后辅助治疗，以改善治疗效果。对于因身体状况无法接受标准含顺铂化疗的患者而言，此次批准意味着治疗路径的拓宽。这一决定有望影响加拿大的临床实践指南，并为类似患者群体带来新的希望。医疗专业人士可将此方案纳入综合治疗策略中，以优化患者的长期预后。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4592","BK4581","IE00BLSP4452.SGD","LU0306807586.USD","LU2596442595.SGD","LU1066051498.USD","SG9999001176.SGD","BK4599","SG9999002224.SGD","LU0225284248.USD","IE0002270589.USD","LU1894683348.USD","IE000M9KFDE8.USD","LU1023059063.AUD","IE00BLSP4239.USD","SG9999013999.USD","SG9999003800.SGD","BK4568","BK4550","LU0225771236.USD","LU1894683264.USD","SG9999011175.SGD","LU0122379950.USD","BK4007","BK4585","LU0456855351.SGD","LU0321505439.SGD","LU0868494617.USD","BK4533","LU0234572021.USD","BK4588","SG9999002232.USD","LU0058720904.USD","LU0985481810.HKD","IE00B3T34201.USD","LU1066053197.SGD","LU0170899867.USD","IE00B19Z3581.USD","LU0306806265.USD","PFE","LU1883839398.USD","LU0289739699.SGD","LU0321505868.SGD","LU1057294990.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","SG9999001176.USD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148306462","title":"辉瑞GLP-1药物通过中国医保药品目录初审","url":"https://stock-news.laohu8.com/highlight/detail?id=1148306462","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148306462?lang=zh_cn&edition=full","pubTime":"2026-06-29 13:01","pubTimestamp":1782709312,"startTime":"0","endTime":"0","summary":"辉瑞公司研发的一款GLP-1类药物，已成功通过中国国家医保药品目录的初步形式审查。根据官方发布的声明，这一进展标志着该药物在纳入国家基本医疗保险报销体系的过程中迈出了关键一步。\n药物通过初审，意味着其相关资料符合申报要求，获得了进入后续专家评审等环节的资格。最终能否被正式纳入医保目录，将取决于其临床价值、患者需求、以及医保基金承受能力等多方面的综合评估。\n这一消息受到市场密切关注。GLP-1类药物在治疗糖尿病和肥胖症等领域展现出显著疗效，全球市场需求旺盛。若辉瑞的该款药物最终成功进入中国医保目录，将有望提升其在中国市场的可及性与竞争力，惠及更广泛的患者群体。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","IE00B19Z3581.USD","LU0321505439.SGD","LU0868494617.USD","BK4568","BK4585","SG9999013999.USD","LU0170899867.USD","LU0985481810.HKD","IE000M9KFDE8.USD","BK4592","IE00B19Z3B42.SGD","LU0058720904.USD","LU1057294990.SGD","IE00B3T34201.USD","LU0289739699.SGD","LU2596442595.SGD","LU0456855351.SGD","BK4533","SG9999002224.SGD","LU1023059063.AUD","BK4550","LU0225771236.USD","LU0321505868.SGD","LU1883839398.USD","LU1066051498.USD","BK4588","IE0002270589.USD","PFE","LU0234572021.USD","SG9999002232.USD","SG9999011175.SGD","SG9999003800.SGD","LU0122379950.USD","LU0306807586.USD","LU1894683348.USD","BK4534","LU1066053197.SGD","LU1894683264.USD","BK4581","BK4007","SGXZ57979304.SGD","IE00BLSP4239.USD","LU0306806265.USD","SG9999001176.SGD","BK4599","IE00BBT3K403.USD","LU0225284248.USD","SG9999001176.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646022801","title":"耐克挖角辉瑞CFO，助力公司推进转型重振投资者信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2646022801","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646022801?lang=zh_cn&edition=full","pubTime":"2026-06-25 23:20","pubTimestamp":1782400836,"startTime":"0","endTime":"0","summary":"此次人事调整正值耐克面临转型压力之际。根据耐克公告，Denton于2022年加入辉瑞担任CFO，此前曾在家居零售商劳氏和医疗健康企业西维斯健康担任财务高管，拥有丰富的大型跨国企业财务管理经验。市场人士认为，新任CFO未来如何推动盈利改善、提升运营效率以及恢复投资者信心，将成为耐克下一阶段转型成败的重要观察指标。","market":"fut","thumbnail":"https://static.tigerbbs.com/68ab55b396d2dcbb09b0c2d9d4f9ce61","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/68ab55b396d2dcbb09b0c2d9d4f9ce61"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1459084.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0823411888.USD","PFE","LU0310800379.SGD","BK4581","LU0306806265.USD","BK4561","BK4558","LU1894683348.USD","LU0786609619.USD","LU0052756011.USD","LU0029864427.USD","LU0225284248.USD","IE00BYQQ9H92.USD","NKE","LU1023059063.AUD","BK4534","IE00B3T34201.USD","IE00BBT3K403.USD","LU0289739699.SGD","LU0708994859.HKD","LU0225771236.USD","LU1267930573.SGD","LU1267930813.SGD","BK4146","LU0122379950.USD","LU0128525929.USD","LU1303367103.USD","LU0058720904.USD","LU0306807586.USD","LU0456855351.SGD","BK4007","IE000M9KFDE8.USD","SG9999001176.SGD","SG9999011175.SGD","LU0234572021.USD","BK4568","IE00BLSP4239.USD","SGXZ57979304.SGD","LU0985481810.HKD","BK4566","BK4592","LU0128525689.USD","LU0321505868.SGD","LU1267930227.SGD","LU1883839398.USD","LU1894683264.USD","BK4550","LU0889566641.SGD","IE00BLSP4452.SGD","LU0321505439.SGD","SG9999002232.USD","LU0170899867.USD","LU1066051498.USD","SG9999013999.USD","IE0002270589.USD","LU0310800965.SGD","LU1057294990.SGD","IE00BFXG0V08.USD","SG9999001176.USD","SG9999002224.SGD","LU2596442595.SGD","IE00B19Z3581.USD","BK4585","LU1066053197.SGD","BK4533","BK4599","BK4588","IE00B19Z3B42.SGD","LU0792757196.USD","LU2098885051.SGD","LU0868494617.USD","SG9999003800.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195591415","title":"维立志博-B完成B轮融资，辉瑞风投领投，Deep Track Capital、GV与Aditum Bio跟投","url":"https://stock-news.laohu8.com/highlight/detail?id=1195591415","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195591415?lang=zh_cn&edition=full","pubTime":"2026-06-25 18:42","pubTimestamp":1782384143,"startTime":"0","endTime":"0","summary":"南京维立志博生物科技有限公司近日成功完成B轮融资。本轮融资由辉瑞旗下的风险投资部门辉瑞风投领投，Deep Track Capital、GV以及Aditum Bio共同参与投资。维立志博-B是一家专注于肿瘤免疫治疗及自身免疫性疾病领域创新抗体药物研发的生物技术公司。辉瑞风投的领投，结合Deep Track Capital、GV和Aditum Bio等专业投资机构的共同参与，彰显了资本市场对维立志博-B研发平台与技术潜力的高度认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ57979304.SGD","BK4592","BK1161","LU1883839398.USD","09887","LU1057294990.SGD","SG9999002224.SGD","SG9999011175.SGD","IE00BLSP4239.USD","LU1023059063.AUD","IE00B19Z3581.USD","BK4581","HK0000252152.HKD","LU0868494617.USD","SG9999001176.SGD","SG9999003800.SGD","IE00BBT3K403.USD","BK4599","BK4550","IE0002270589.USD","BK4007","LU0122379950.USD","LU0321505868.SGD","IE00BLSP4452.SGD","LU0456855351.SGD","LU0225284248.USD","IE00B3T34201.USD","IE00B19Z3B42.SGD","HK0000252160.HKD","LU1894683264.USD","LU0289739699.SGD","LU1894683348.USD","LU0985481810.HKD","BK4568","PFE","SG9999013999.USD","LU0306807586.USD","BK4534","LU2596442595.SGD","SG9999002232.USD","LU0225771236.USD","IE000M9KFDE8.USD","LU0321505439.SGD","LU0058720904.USD","LU1066053197.SGD","SG9999001176.USD","HK0000500386.USD","LU1066051498.USD","LU0170899867.USD","LU0234572021.USD","BK4588","BK4585","BK4533","LU0306806265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646753888","title":"外商借链博会等国际展会加深布局中国市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2646753888","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646753888?lang=zh_cn&edition=full","pubTime":"2026-06-25 16:43","pubTimestamp":1782377026,"startTime":"0","endTime":"0","summary":"在日前于北京举行的第四届中国国际供应链促进博览会(以下简称“链博会”)和多场国际级行业会议上，多国外商积极参与，不仅丰富了产业链资源、加强了供应链韧性，还纷纷通过推出创新服务和产品加深布局中国市场。松下控股株式会社执行董事、集团中国东北亚总代表中山正春对记者表示，公司连续多届参与链博会，对接触产业和市场非常有益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606253783107245.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0456855351.SGD","LU0170899867.USD","LU1894683264.USD","BK4209","IE00BLSP4239.USD","LU0456842615.SGD","LU0225284248.USD","BK4581","LU0306806265.USD","BK4007","LU0320764755.SGD","BK4585","LU0234572021.USD","LU0128525929.USD","LU0672654166.SGD","SGXZ57979304.SGD","LU0348825331.USD","SG9999003800.SGD","BK0210","YUMC","LU0985481810.HKD","IE0002270589.USD","LU0321505439.SGD","IE00B19Z3581.USD","SG9999013999.USD","LU1023059063.AUD","LU0594300419.USD","BK4504","BK4533","SG9999011175.SGD","LU0359202008.SGD","IE00B0JY6N72.USD","LU2596442595.SGD","BK4534","LU0650527681.SGD","LU2008162690.USD","LU2177674079.SGD","HK0000306701.USD","IE00B3T34201.USD","BK4531","SG9999002232.USD","LU1023057109.AUD","LU2279701549.SGD","LU0122379950.USD","LU1051768304.USD","LU0359201612.USD","LU0651946864.USD","PFE","LU1267930573.SGD","LU1894683348.USD","IE00BGV7N243.SGD","LU0058720904.USD","LU0310800379.SGD","IE0034224299.USD","LU0228659784.USD","LU1066053197.SGD","300795","BK4588","LU0868494617.USD","LU0321505868.SGD","LU0543330483.HKD","LU1057294990.SGD","HK0000306685.HKD","LU0289739699.SGD","LU0029864427.USD","IE00BBT3K403.USD","LU0823426308.USD","LU1883839398.USD","LU0868486357.SGD","LU0417516902.SGD","LU0708994859.HKD","LU0431992006.USD","IE000M9KFDE8.USD","BK4592","LU1515016050.SGD","BK4599","BK4526","LU0306807586.USD","IE00B19Z3B42.SGD","LU0128522157.USD","BK4568","09987","LU0572944931.SGD","IE00BLSP4452.SGD","HK0000320264.USD","SG9999001176.SGD","LU0823426480.USD","SG9999002224.SGD","SG9999001176.USD","LU1066051498.USD","BK4550","LU0029875118.USD","LU0327786744.USD","HK0000320223.HKD","IE0003895053.USD","LU0225771236.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646250843","title":"辉瑞：董事会批准每股 0.43 美元季度现金股息。","url":"https://stock-news.laohu8.com/highlight/detail?id=2646250843","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646250843?lang=zh_cn&edition=full","pubTime":"2026-06-25 03:55","pubTimestamp":1782330927,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BLSP4239.USD","SG9999002224.SGD","BK4588","SG9999001176.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1894683264.USD","LU1066053197.SGD","BK4599","IE00B3T34201.USD","BK4534","LU0289739699.SGD","SGXZ57979304.SGD","IE000M9KFDE8.USD","LU0321505868.SGD","LU0234572021.USD","IE0002270589.USD","LU0306807586.USD","SG9999011175.SGD","BK4585","BK4533","IE00BBT3K403.USD","LU1894683348.USD","LU0225284248.USD","BK4581","BK4550","BK4592","LU1066051498.USD","SG9999003800.SGD","BK4007","PFE","LU0306806265.USD","LU0868494617.USD","BK4568","SG9999001176.SGD","SG9999013999.USD","LU2596442595.SGD","SG9999002232.USD","LU0321505439.SGD","LU0058720904.USD","LU0456855351.SGD","LU1883839398.USD","LU0122379950.USD","LU1023059063.AUD","LU1057294990.SGD","IE00BLSP4452.SGD","LU0170899867.USD","LU0985481810.HKD","LU0225771236.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136844385","title":"异动解读｜辉瑞盘中下跌3.03%，核心肿瘤管线三期临床失利叠加高管离职持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1136844385","media":"行情直击","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136844385?lang=zh_cn&edition=full","pubTime":"2026-06-25 01:36","pubTimestamp":1782322610,"startTime":"0","endTime":"0","summary":"6月24日，辉瑞盘中下跌3.03%，报23.97美元/股，成交额10.23亿美元。消息面上，辉瑞近期利空因素密集释放。公司核心肿瘤管线药物Sigvotatug Vedotin三期临床试验结果显示未能显著改善患者总生存期，对公司寄予厚望的肿瘤领域布局构成明显打击，市场对其未来收入潜力进行重新评估。公司虽重申了财年指引，但未能提振市场信心，多重利空叠加下辉瑞持续走弱。辉瑞所在的制药行业中，礼来跌0.49%，诺华跌0.25%，强生跌0.05%，默沙东涨0.62%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161578237","title":"三期研究结果出炉：Sigvotatug Vedotin未能改善总生存期，盘后辉瑞股价应声下跌1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1161578237","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161578237?lang=zh_cn&edition=full","pubTime":"2026-06-23 04:41","pubTimestamp":1782160897,"startTime":"0","endTime":"0","summary":"辉瑞公司股价在盘后交易中下跌了1%。此前，该公司公布了其药物Sigvotatug Vedotin的三期临床试验结果，数据显示该药物未能显著改善患者的总体生存期。\n这一结果对辉瑞寄予厚望的肿瘤管线构成了打击。市场迅速对此消息做出了反应，投资者信心受到考验。股价的波动反映了市场对研发进展的高度敏感，以及对未来收入潜力的重新评估。\n尽管遭遇挫折，辉瑞的总体研发管线依然庞大。公司表示将继续推进其他在研项目。然而，此次关键研究的失利无疑为相关领域的竞争格局增添了变数，也凸显了新药开发固有的高风险性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ57979304.SGD","BK4592","LU1883839398.USD","LU1057294990.SGD","SG9999002224.SGD","SG9999011175.SGD","IE00BLSP4239.USD","LU1023059063.AUD","IE00B19Z3581.USD","BK4581","LU0868494617.USD","SG9999001176.SGD","SG9999003800.SGD","IE00BBT3K403.USD","BK4599","BK4550","IE0002270589.USD","BK4007","LU0122379950.USD","LU0321505868.SGD","IE00BLSP4452.SGD","LU0456855351.SGD","LU0225284248.USD","IE00B3T34201.USD","IE00B19Z3B42.SGD","LU1894683264.USD","LU0289739699.SGD","LU1894683348.USD","LU0985481810.HKD","BK4568","PFE","SG9999013999.USD","LU0306807586.USD","BK4534","LU2596442595.SGD","SG9999002232.USD","LU0225771236.USD","IE000M9KFDE8.USD","LU0321505439.SGD","LU0058720904.USD","LU1066053197.SGD","SG9999001176.USD","LU1066051498.USD","LU0170899867.USD","LU0234572021.USD","BK4588","BK4585","BK4533","LU0306806265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128127312","title":"辉瑞公布Sigvotatug Vedotin用于经治转移性非鳞状非小细胞肺癌的III期临床试验关键结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1128127312","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128127312?lang=zh_cn&edition=full","pubTime":"2026-06-23 04:30","pubTimestamp":1782160254,"startTime":"0","endTime":"0","summary":"辉瑞公司宣布，其候选药物Sigvotatug Vedotin在针对既往接受过治疗的转移性非鳞状非小细胞肺癌患者的III期临床试验中，已获得关键性顶线结果。该消息标志着该药物在这一难治性癌症适应症开发进程中的重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","IE00B19Z3581.USD","IE00BBT3K403.USD","LU0306807586.USD","LU0456855351.SGD","SG9999003800.SGD","IE00BLSP4239.USD","BK4007","SG9999013999.USD","LU0122379950.USD","LU1894683348.USD","LU0289739699.SGD","LU0225284248.USD","LU0985481810.HKD","PFE","IE00BLSP4452.SGD","LU0234572021.USD","LU1057294990.SGD","LU0058720904.USD","LU0170899867.USD","BK4585","LU0225771236.USD","LU0321505439.SGD","SG9999002232.USD","LU1894683264.USD","IE0002270589.USD","IE00B3T34201.USD","SGXZ57979304.SGD","IE000M9KFDE8.USD","SG9999011175.SGD","LU1066051498.USD","SG9999002224.SGD","BK4533","BK4568","LU0306806265.USD","LU1883839398.USD","LU0321505868.SGD","BK4581","BK4534","BK4588","BK4592","LU2596442595.SGD","SG9999001176.USD","SG9999001176.SGD","IE00B19Z3B42.SGD","LU1066053197.SGD","LU1023059063.AUD","LU0868494617.USD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149924240","title":"异动解读｜辉瑞盘中下跌3.03%，首席财务官官宣离职引发市场波动","url":"https://stock-news.laohu8.com/highlight/detail?id=1149924240","media":"行情直击","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149924240?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:24","pubTimestamp":1781792699,"startTime":"0","endTime":"0","summary":"6月18日，辉瑞盘中下跌3.03%，报25.115美元/股，成交额5.49亿美元。消息面上，辉瑞披露高管人事变动公告，公司首席财务官戴夫·丹顿将于8月15日正式离职，后续将转战消费品行业发展。公司已任命Cecile Guegan为临时首席财务官。丹顿于2022年加入辉瑞执掌财务运营工作，入职前曾历任劳氏、CVS Health首席财务官，具备丰富的大型企业财务管控经验。核心高管突然离任加剧了市场对公司管理层稳定性的担忧，叠加制药板块整体承压，辉瑞股价明显走弱。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644863300","title":"辉瑞(PFE)官宣首席财务官8月离职 内部高管接任临时财务负责人","url":"https://stock-news.laohu8.com/highlight/detail?id=2644863300","media":"金吾财讯","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644863300?lang=zh_cn&edition=full","pubTime":"2026-06-18 20:47","pubTimestamp":1781786876,"startTime":"0","endTime":"0","summary":"金吾财讯 | 美国制药巨头辉瑞 周四披露高管人事变动公告，公司首席财务官戴夫·丹顿将于8月15日正式离职，后续将转战消费品行业发展。戴夫·丹顿于2022年加入辉瑞执掌财务运营工作，入职前曾历任劳氏、CVS Health首席财务官，具备丰富的大型企业财务管控经验。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/NjEzNTY0MzU5MDE2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NjEzNTY0MzU5MDE2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301697","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","LU1894683264.USD","SG9999001176.USD","SG9999002232.USD","LU1023059063.AUD","SG9999013999.USD","IE00BLSP4452.SGD","BK4568","LU0225771236.USD","PFE","LU1894683348.USD","BK4534","LU0306806265.USD","LU0868494617.USD","IE000M9KFDE8.USD","BK4550","BK4581","LU0321505868.SGD","LU1883839398.USD","LU2596442595.SGD","BK4007","LU1057294990.SGD","SG9999002224.SGD","IE00B3T34201.USD","SG9999011175.SGD","IE00BBT3K403.USD","IE0002270589.USD","BK4588","LU0122379950.USD","IE00B19Z3581.USD","LU0306807586.USD","LU0225284248.USD","SG9999003800.SGD","SG9999001176.SGD","LU0170899867.USD","BK4599","LU0321505439.SGD","SGXZ57979304.SGD","BK4533","LU0456855351.SGD","BK4592","LU1066051498.USD","LU0289739699.SGD","LU0985481810.HKD","LU0058720904.USD","LU1066053197.SGD","IE00BLSP4239.USD","BK4585","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pfizer.com","stockEarnings":[{"period":"1week","weight":-0.0062},{"period":"1month","weight":-0.0559},{"period":"3month","weight":-0.1022},{"period":"6month","weight":-0.0514},{"period":"1year","weight":-0.0625},{"period":"ytd","weight":-0.0293}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1111},{"period":"6month","weight":0.0877},{"period":"1year","weight":0.2063},{"period":"ytd","weight":0.1071}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"辉瑞公司于1942年6月2日根据特拉华州法律成立。公司是一家以研究为基础的全球性生物制药公司。公司运用科学和全球资源，通过发现、开发、制造和分销保健产品（包括创新药物和疫苗），为人们带来延长和显著改善其生活的疗法。公司在发达国家和新兴市场开展工作，致力于促进健康、预防、治疗和治愈这个时代最令人恐惧的疾病。公司与医疗保健提供商、政府和当地社区合作，支持并扩大在全球范围内获得可靠、负担得起的医疗保健服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.456522,"avgChangeRate":0.002542},{"month":2,"riseRate":0.456522,"avgChangeRate":-0.005934},{"month":3,"riseRate":0.608696,"avgChangeRate":0.014732},{"month":4,"riseRate":0.574468,"avgChangeRate":0.016819},{"month":5,"riseRate":0.489362,"avgChangeRate":0.007168},{"month":6,"riseRate":0.489362,"avgChangeRate":0.001032},{"month":7,"riseRate":0.489362,"avgChangeRate":0.011195},{"month":8,"riseRate":0.456522,"avgChangeRate":0.0002},{"month":9,"riseRate":0.456522,"avgChangeRate":0.004432},{"month":10,"riseRate":0.630435,"avgChangeRate":0.013042},{"month":11,"riseRate":0.695652,"avgChangeRate":0.028255},{"month":12,"riseRate":0.5,"avgChangeRate":0.008452}],"exchange":"NYSE","name":"辉瑞","nameEN":"Pfizer"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供辉瑞(PFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"辉瑞,PFE,辉瑞股票,辉瑞股票老虎,辉瑞股票老虎国际,辉瑞行情,辉瑞股票行情,辉瑞股价,辉瑞股市,辉瑞股票价格,辉瑞股票交易,辉瑞股票购买,辉瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供辉瑞(PFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}